Have your own idea? Try our Stock Screener
Chinese (SSE) Healthcare Sector Analysis
UpdatedJul 17, 2025
DataAggregated Company Financials
Companies466
- 7D3.3%
- 3M13.1%
- 1Y21.6%
- YTD14.6%
The Healthcare industry is up 2.7% in the last week, with WuXi AppTec up 13%. Meanwhile, Qianjiang Yongan Pharmaceutical actually underperformed within the industry, shrinking 17% in the last week. In the last 12 months, the industry was up 22%. Earnings are forecast to grow by 22% annually.
Sector Valuation and Performance
Has the Chinese Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 17 Jul 2025 | CN¥6.3t | CN¥2.2t | CN¥150.0b | 37.4x | 41.8x | 2.9x |
| Sat, 14 Jun 2025 | CN¥6.1t | CN¥2.2t | CN¥150.0b | 35.5x | 40.6x | 2.8x |
| Mon, 12 May 2025 | CN¥5.6t | CN¥2.2t | CN¥149.6b | 33.8x | 37.6x | 2.6x |
| Wed, 09 Apr 2025 | CN¥5.4t | CN¥2.2t | CN¥158.8b | 30.1x | 33.9x | 2.4x |
| Fri, 07 Mar 2025 | CN¥5.8t | CN¥2.2t | CN¥153.7b | 32.8x | 37.4x | 2.6x |
| Sun, 02 Feb 2025 | CN¥5.4t | CN¥2.2t | CN¥153.8b | 30.9x | 34.9x | 2.4x |
| Tue, 31 Dec 2024 | CN¥5.7t | CN¥2.2t | CN¥153.7b | 32x | 36.9x | 2.5x |
| Thu, 28 Nov 2024 | CN¥5.9t | CN¥2.2t | CN¥154.1b | 33.6x | 38.2x | 2.6x |
| Sat, 26 Oct 2024 | CN¥5.9t | CN¥2.3t | CN¥161.9b | 32.4x | 36.5x | 2.6x |
| Mon, 23 Sep 2024 | CN¥4.7t | CN¥2.2t | CN¥161.8b | 26.4x | 29.2x | 2.1x |
| Wed, 21 Aug 2024 | CN¥5.0t | CN¥2.3t | CN¥166.0b | 27.2x | 30.1x | 2.2x |
| Fri, 19 Jul 2024 | CN¥5.2t | CN¥2.3t | CN¥166.9b | 28.4x | 31.1x | 2.3x |
| Sun, 16 Jun 2024 | CN¥5.5t | CN¥2.3t | CN¥164.9b | 29.7x | 33.2x | 2.4x |
| Tue, 14 May 2024 | CN¥6.0t | CN¥2.3t | CN¥167.5b | 32.2x | 36x | 2.6x |
| Thu, 11 Apr 2024 | CN¥5.7t | CN¥2.3t | CN¥172.9b | 29.8x | 32.8x | 2.5x |
| Sat, 09 Mar 2024 | CN¥5.8t | CN¥2.3t | CN¥178.9b | 29.6x | 32.3x | 2.5x |
| Mon, 05 Feb 2024 | CN¥5.1t | CN¥2.3t | CN¥177.1b | 25.9x | 29x | 2.2x |
| Wed, 03 Jan 2024 | CN¥6.5t | CN¥2.3t | CN¥176.8b | 34.9x | 36.7x | 2.8x |
| Fri, 01 Dec 2023 | CN¥6.7t | CN¥2.3t | CN¥177.2b | 36.7x | 38.1x | 3x |
| Sun, 29 Oct 2023 | CN¥6.4t | CN¥2.3t | CN¥186.2b | 33.1x | 34.3x | 2.8x |
| Tue, 26 Sep 2023 | CN¥6.4t | CN¥2.3t | CN¥185.2b | 32.3x | 34.5x | 2.8x |
| Thu, 24 Aug 2023 | CN¥6.0t | CN¥2.3t | CN¥192.4b | 30.3x | 31.1x | 2.6x |
| Sat, 22 Jul 2023 | CN¥6.5t | CN¥2.3t | CN¥193.0b | 33.4x | 33.6x | 2.9x |
| Mon, 19 Jun 2023 | CN¥6.7t | CN¥2.3t | CN¥191.7b | 35.2x | 35.2x | 3x |
| Wed, 17 May 2023 | CN¥7.0t | CN¥2.3t | CN¥192.0b | 35.3x | 36.4x | 3.1x |
| Fri, 14 Apr 2023 | CN¥7.3t | CN¥2.2t | CN¥236.4b | 37.9x | 31x | 3.3x |
| Sun, 12 Mar 2023 | CN¥7.1t | CN¥2.2t | CN¥229.9b | 37.9x | 30.9x | 3.2x |
| Tue, 07 Feb 2023 | CN¥7.3t | CN¥2.2t | CN¥233.2b | 38.3x | 31.4x | 3.3x |
| Thu, 05 Jan 2023 | CN¥6.9t | CN¥2.2t | CN¥232.3b | 36x | 29.9x | 3.2x |
| Sat, 03 Dec 2022 | CN¥7.0t | CN¥2.2t | CN¥231.9b | 37.5x | 30.3x | 3.2x |
| Mon, 31 Oct 2022 | CN¥6.5t | CN¥2.2t | CN¥229.8b | 35.9x | 28.4x | 3x |
| Wed, 28 Sep 2022 | CN¥6.1t | CN¥2.1t | CN¥223.5b | 30.9x | 27.2x | 2.9x |
| Fri, 26 Aug 2022 | CN¥6.5t | CN¥2.1t | CN¥229.3b | 32x | 28.2x | 3.1x |
| Sun, 24 Jul 2022 | CN¥6.7t | CN¥2.1t | CN¥225.2b | 32.8x | 29.9x | 3.3x |
Price to Earnings Ratio
29.9x
Current Industry PE
- Investors are optimistic on the Chinese Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 41.4x which is higher than its 3-year average PE of 33.6x.
- The industry is trading close to its 3-year average PS ratio of 2.8x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 13% per year over the last three years.
- Meanwhile revenues for these companies have grown 2.2% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare sector?
| CN Market | 0.62% | |
| Healthcare | 3.30% | |
| Life Sciences | 6.57% | |
| Healthtech | 4.05% | |
| Pharma | 3.75% | |
| Biotech | 3.73% | |
| Healthcare Services | 2.37% | |
| Medical Equipment | 0.96% | |
Industry PE
- Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio of 52.2x.
- Analysts are expecting annual earnings growth of 42.1%, which is higher than its past year's earnings decline of 17.7% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 63% over the next 5 years.
- This is better than its past earnings decline of 43% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 14% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 603259 WuXi AppTec | CN¥81.02 | 15.5% +CN¥31.0b | 106.0% | PE17.7x | |
| 002294 Shenzhen Salubris Pharmaceuticals | CN¥53.15 | 17.5% +CN¥8.8b | 87.0% | PE98.5x | |
| 688166 BrightGene Bio-Medical Technology | CN¥75.21 | 34.1% +CN¥8.1b | 140.1% | PE230.1x | |
| 000963 Huadong Medicine | CN¥43.94 | 10.3% +CN¥7.2b | 53.4% | PE21.6x | |
| 688382 InventisBio | CN¥42.77 | 37.7% +CN¥6.8b | 480.3% | PS146.9x |